LyndraInc Profile Banner
Lyndra® Therapeutics Profile
Lyndra® Therapeutics

@LyndraInc

Followers
306
Following
71
Media
201
Statuses
542

As of March 26, 2025, Lyndra Therapeutics has ceased operations. Please direct any inquiries by email to Craig Jalbert at [email protected].

Watertown, MA
Joined March 2017
Don't wanna be here? Send us removal request.
@LyndraInc
Lyndra® Therapeutics
2 years
We’re honored to announce the close of a $101 Million Series E funding round, led by Sarissa Capital and including Sun Pharma and Polaris Partners, to support the development of therapies with our LYNXTM drug delivery platform.
Tweet card summary image
businesswire.com
Lyndra Therapeutics closed a $101 million Series E financing round led by Sarissa Capital and including Sun Pharma and Polaris Partners.
0
0
2
@LyndraInc
Lyndra® Therapeutics
2 years
Lyndra has announced leadership changes and an update on pivotal trial progress! Learn more about the announcement in our press release:
Tweet media one
1
0
3
@LyndraInc
Lyndra® Therapeutics
2 years
RT @HCPLiveNews: A new trial testing risperidone (LYN-005) as a weekly oral treatment for patients with #schizophrenia has officially begun….
Tweet card summary image
hcplive.com
The LYNX drug development platform is able to deliver drug consistently, while minimizing peaks and troughs of drug levels compared to daily medicine.
0
1
0
@LyndraInc
Lyndra® Therapeutics
2 years
Today Lyndra announced the dosing of the first participant in our pivotal trial evaluating oral weekly risperidone (LYN-005) in adults with schizophrenia or schizoaffective disorder. Read more here: #Lynx #Innovation #Biotech
Tweet media one
0
2
8
@LyndraInc
Lyndra® Therapeutics
2 years
Learn more here: #WomanCEO.
0
0
0
@LyndraInc
Lyndra® Therapeutics
2 years
Our CEO @TrishHurter is joining @MIT's 4th Symposium of the International Consortium for Advanced Medicines Manufacturing (ICAMM), in Cambridge, MA from April 27-28. Her talk, “Celebrating Success: Advanced #Manufacturing of Small Molecules,” starts at 10:00 AM EST tomorrow.
Tweet media one
1
0
2
@LyndraInc
Lyndra® Therapeutics
2 years
Many Lyndra team members bring a personal passion to their work, including our CEO @TrishHurter. In recognition of the @WHO's #WorldMalariaDay today, read Trish’s personal story of her commitment to malaria eradication & how it inspires her work at Lyndra:
Tweet card summary image
linkedin.com
Growing up in South Africa, I knew malaria was a threat throughout the African continent, but it was not prevalent in the cities and towns where I lived and went to school. My first personal encoun...
0
1
2
@LyndraInc
Lyndra® Therapeutics
2 years
She’ll be talking about the initiation of our pivotal trial for oral weekly risperidone (LYN-005), a long-acting oral pill being evaluated for the treatment of schizophrenia or schizoaffective disorder. Learn more here:
Tweet card summary image
watertownbusinesscoalition.com
Events See Events Calendar
0
1
1
@LyndraInc
Lyndra® Therapeutics
2 years
Our President and Chief Operations Officer @JBallLyndra will be joining the @WatertownBiz annual Life Science panel on April 25 at 5:30 PM EST, at the Mosesian Center. #Watertown #LifeSciences
Tweet media one
1
1
4
@LyndraInc
Lyndra® Therapeutics
2 years
We look forward to a world where long-acting oral therapies can help to better “achieve health for all.”. Read more about the #LYNX drug delivery platform, designed to deliver long-acting oral therapies here:
lyndra.com
Lyndra’s LYNX™ drug delivery platform incorporates more than 20 patented innovations to achieve dramatically reduced dosing frequency.
0
0
1
@LyndraInc
Lyndra® Therapeutics
2 years
@WHO notes that schizophrenia affects ~24 million people worldwide. Despite effective treatment options, medication adherence is a struggle for many.
1
0
2
@LyndraInc
Lyndra® Therapeutics
2 years
This year’s #WorldHealthDay’s theme of #HealthForAll is close to our hearts, given our efforts to improve how oral medicines are delivered, starting with serious mental health conditions like schizophrenia. #WHO75
Tweet media one
1
0
1
@LyndraInc
Lyndra® Therapeutics
2 years
Spring has sprung! We’re celebrating new opportunities as we head into the warmer months in Boston. The season represents rebirth & rejuvenation, carrying an important weight for many cultures. We’re wishing a Happy Easter, Happy Passover & Ramadan Mubarak to those who celebrate
Tweet media one
0
1
1
@LyndraInc
Lyndra® Therapeutics
2 years
Our President & COO @JballLyndra is speaking at @HarvardGSAS Biotech Club’s distinguished speaker series today, April 6. She will share her career journey & work since joining Lyndra to finance, build partnerships, manage operations & her advice for the next generation in #STEM
Tweet media one
0
1
2
@LyndraInc
Lyndra® Therapeutics
2 years
According to @NAMIcommunicate, around 7 million people in the U.S. live with bipolar disorder. @WorldBipolarDay aims to address stigma through education; we recommend a recent blog from NAMI titled "Understanding Bipolar Disorder": .
Tweet media one
0
0
1
@LyndraInc
Lyndra® Therapeutics
2 years
In honor of #WomensHistoryMonth, we’re sharing this quote from our President and Chief Operations Officer @JBallLyndra on her path to success from @ISPEOrg’s Facilities of the Future Conference. Check out quotes from Jess and other panelists: . #IWD2023
Tweet media one
0
0
1
@LyndraInc
Lyndra® Therapeutics
2 years
Our director of R&D Ops and Risk Management Divya Krishnamurthy, Ph.D., is a featured speaker at the #LabFacilitiesSummit in Boston. Her March 23 roundtable will cover health and safety guidelines, emergency action, waste disposal and recycling.
Tweet media one
1
1
5
@LyndraInc
Lyndra® Therapeutics
2 years
What makes #Lyndra’s approach to oral drug delivery unique? Our Chief Medical Officer Richard Scranton, MD, MPH, speaks about how, as part of our core purpose to reinvent medicine for a healthier world, we’re aiming to fundamentally change how pills work. #Adherence
0
2
2